img

Global Autoimmune Disease Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autoimmune Disease Drug Market Insights, Forecast to 2034

Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
Market Analysis and InsightsGlobal Autoimmune Disease Drug Market
Global Autoimmune Disease Drug market is expected to reach to US$ 6587 million in 2024, with a positive growth of %, compared with US$ 6080 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Autoimmune Disease Drug industry is evaluated to reach US$ 10220 million in 2029. The CAGR will be 7.6% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Autoimmune Disease Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Autoimmune Disease Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Segment by Type
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others

Segment by Application


Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Autoimmune Disease Drug introduction, etc. Autoimmune Disease Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Autoimmune Disease Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Anti-Inflammatory
1.2.4 Interferons
1.2.5 Antihyperglycemics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Type 1 Diabetes
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Lupus
1.3.7 Inflammatory Bowel Disease
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Drug Market Perspective (2018-2029)
2.2 Global Autoimmune Disease Drug Growth Trends by Region
2.2.1 Autoimmune Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Autoimmune Disease Drug Historic Market Size by Region (2018-2024)
2.2.3 Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029)
2.3 Autoimmune Disease Drug Market Dynamics
2.3.1 Autoimmune Disease Drug Industry Trends
2.3.2 Autoimmune Disease Drug Market Drivers
2.3.3 Autoimmune Disease Drug Market Challenges
2.3.4 Autoimmune Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Autoimmune Disease Drug by Players
3.1.1 Global Autoimmune Disease Drug Revenue by Players (2018-2024)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2018-2024)
3.2 Global Autoimmune Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Autoimmune Disease Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Autoimmune Disease Drug Market Concentration Ratio
3.4.1 Global Autoimmune Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Drug Revenue in 2022
3.5 Global Key Players of Autoimmune Disease Drug Head office and Area Served
3.6 Global Key Players of Autoimmune Disease Drug, Product and Application
3.7 Global Key Players of Autoimmune Disease Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Drug Breakdown Data by Type
4.1 Global Autoimmune Disease Drug Historic Market Size by Type (2018-2024)
4.2 Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029)
5 Autoimmune Disease Drug Breakdown Data by Application
5.1 Global Autoimmune Disease Drug Historic Market Size by Application (2018-2024)
5.2 Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Autoimmune Disease Drug Market Size (2018-2029)
6.2 North America Autoimmune Disease Drug Market Size by Type
6.2.1 North America Autoimmune Disease Drug Market Size by Type (2018-2024)
6.2.2 North America Autoimmune Disease Drug Market Size by Type (2024-2029)
6.2.3 North America Autoimmune Disease Drug Market Share by Type (2018-2029)
6.3 North America Autoimmune Disease Drug Market Size by Application
6.3.1 North America Autoimmune Disease Drug Market Size by Application (2018-2024)
6.3.2 North America Autoimmune Disease Drug Market Size by Application (2024-2029)
6.3.3 North America Autoimmune Disease Drug Market Share by Application (2018-2029)
6.4 North America Autoimmune Disease Drug Market Size by Country
6.4.1 North America Autoimmune Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Autoimmune Disease Drug Market Size by Country (2018-2024)
6.4.3 North America Autoimmune Disease Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Autoimmune Disease Drug Market Size (2018-2029)
7.2 Europe Autoimmune Disease Drug Market Size by Type
7.2.1 Europe Autoimmune Disease Drug Market Size by Type (2018-2024)
7.2.2 Europe Autoimmune Disease Drug Market Size by Type (2024-2029)
7.2.3 Europe Autoimmune Disease Drug Market Share by Type (2018-2029)
7.3 Europe Autoimmune Disease Drug Market Size by Application
7.3.1 Europe Autoimmune Disease Drug Market Size by Application (2018-2024)
7.3.2 Europe Autoimmune Disease Drug Market Size by Application (2024-2029)
7.3.3 Europe Autoimmune Disease Drug Market Share by Application (2018-2029)
7.4 Europe Autoimmune Disease Drug Market Size by Country
7.4.1 Europe Autoimmune Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Autoimmune Disease Drug Market Size by Country (2018-2024)
7.4.3 Europe Autoimmune Disease Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Autoimmune Disease Drug Market Size (2018-2029)
8.2 China Autoimmune Disease Drug Market Size by Type
8.2.1 China Autoimmune Disease Drug Market Size by Type (2018-2024)
8.2.2 China Autoimmune Disease Drug Market Size by Type (2024-2029)
8.2.3 China Autoimmune Disease Drug Market Share by Type (2018-2029)
8.3 China Autoimmune Disease Drug Market Size by Application
8.3.1 China Autoimmune Disease Drug Market Size by Application (2018-2024)
8.3.2 China Autoimmune Disease Drug Market Size by Application (2024-2029)
8.3.3 China Autoimmune Disease Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Autoimmune Disease Drug Market Size (2018-2029)
9.2 Asia Autoimmune Disease Drug Market Size by Type
9.2.1 Asia Autoimmune Disease Drug Market Size by Type (2018-2024)
9.2.2 Asia Autoimmune Disease Drug Market Size by Type (2024-2029)
9.2.3 Asia Autoimmune Disease Drug Market Share by Type (2018-2029)
9.3 Asia Autoimmune Disease Drug Market Size by Application
9.3.1 Asia Autoimmune Disease Drug Market Size by Application (2018-2024)
9.3.2 Asia Autoimmune Disease Drug Market Size by Application (2024-2029)
9.3.3 Asia Autoimmune Disease Drug Market Share by Application (2018-2029)
9.4 Asia Autoimmune Disease Drug Market Size by Region
9.4.1 Asia Autoimmune Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Autoimmune Disease Drug Market Size by Region (2018-2024)
9.4.3 Asia Autoimmune Disease Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Drug Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Autoimmune Disease Drug Introduction
11.2.4 Pfizer Revenue in Autoimmune Disease Drug Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Autoimmune Disease Drug Introduction
11.3.4 AbbVie Revenue in Autoimmune Disease Drug Business (2018-2024)
11.3.5 AbbVie Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Autoimmune Disease Drug Introduction
11.4.4 Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Details
11.6.2 AstraZeneca plc Business Overview
11.6.3 AstraZeneca plc Autoimmune Disease Drug Introduction
11.6.4 AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2024)
11.6.5 AstraZeneca plc Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Autoimmune Disease Drug Introduction
11.8.4 Roche Revenue in Autoimmune Disease Drug Business (2018-2024)
11.8.5 Roche Recent Developments
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Autoimmune Disease Drug Introduction
11.9.4 Biogen Revenue in Autoimmune Disease Drug Business (2018-2024)
11.9.5 Biogen Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Drug Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Drug Business (2018-2024)
11.10.5 Amgen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Interferons
Table 5. Key Players of Antihyperglycemics
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Autoimmune Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Market Share by Region (2018-2024)
Table 11. Global Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Autoimmune Disease Drug Market Share by Region (2024-2029)
Table 13. Autoimmune Disease Drug Market Trends
Table 14. Autoimmune Disease Drug Market Drivers
Table 15. Autoimmune Disease Drug Market Challenges
Table 16. Autoimmune Disease Drug Market Restraints
Table 17. Global Autoimmune Disease Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Autoimmune Disease Drug Revenue Share by Players (2018-2024)
Table 19. Global Top Autoimmune Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Table 20. Global Autoimmune Disease Drug Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Autoimmune Disease Drug, Headquarters and Area Served
Table 23. Global Key Players of Autoimmune Disease Drug, Product and Application
Table 24. Global Key Players of Autoimmune Disease Drug, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Autoimmune Disease Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Autoimmune Disease Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Autoimmune Disease Drug Revenue Share by Application (2018-2024)
Table 32. Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Autoimmune Disease Drug Revenue Share by Application (2024-2029)
Table 34. North America Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Autoimmune Disease Drug Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Autoimmune Disease Drug Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Autoimmune Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Autoimmune Disease Drug Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Autoimmune Disease Drug Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Autoimmune Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Autoimmune Disease Drug Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Autoimmune Disease Drug Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Autoimmune Disease Drug Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Autoimmune Disease Drug Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Autoimmune Disease Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Autoimmune Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Autoimmune Disease Drug Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Autoimmune Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Autoimmune Disease Drug Product
Table 69. Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 70. Abbott Laboratories Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Autoimmune Disease Drug Product
Table 74. Pfizer Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Autoimmune Disease Drug Product
Table 79. AbbVie Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 80. AbbVie Recent Developments
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Autoimmune Disease Drug Product
Table 84. Eli Lilly Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 85. Eli Lilly Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Autoimmune Disease Drug Product
Table 89. Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. AstraZeneca plc Company Details
Table 92. AstraZeneca plc Business Overview
Table 93. AstraZeneca plc Autoimmune Disease Drug Product
Table 94. AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 95. AstraZeneca plc Recent Developments
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Autoimmune Disease Drug Product
Table 99. GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 100. GlaxoSmithKline Recent Developments
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Autoimmune Disease Drug Product
Table 104. Roche Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 105. Roche Recent Developments
Table 106. Biogen Company Details
Table 107. Biogen Business Overview
Table 108. Biogen Autoimmune Disease Drug Product
Table 109. Biogen Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 110. Biogen Recent Developments
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Autoimmune Disease Drug Product
Table 114. Amgen Revenue in Autoimmune Disease Drug Business (2018-2024) & (US$ Million)
Table 115. Amgen Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Autoimmune Disease Drug Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Anti-Inflammatory Features
Figure 5. Interferons Features
Figure 6. Antihyperglycemics Features
Figure 7. Others Features
Figure 8. Global Autoimmune Disease Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Autoimmune Disease Drug Market Share by Application: 2022 VS 2029
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Type 1 Diabetes Case Studies
Figure 12. Multiple Sclerosis Case Studies
Figure 13. Psoriasis Case Studies
Figure 14. Lupus Case Studies
Figure 15. Inflammatory Bowel Disease Case Studies
Figure 16. Others Case Studies
Figure 17. Autoimmune Disease Drug Report Years Considered
Figure 18. Global Autoimmune Disease Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Autoimmune Disease Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Autoimmune Disease Drug Market Share by Region: 2022 VS 2029
Figure 21. Global Autoimmune Disease Drug Market Share by Players in 2022
Figure 22. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2022
Figure 24. North America Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Autoimmune Disease Drug Market Share by Type (2018-2029)
Figure 26. North America Autoimmune Disease Drug Market Share by Application (2018-2029)
Figure 27. North America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 28. United States Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Autoimmune Disease Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 31. Europe Autoimmune Disease Drug Market Share by Type (2018-2029)
Figure 32. Europe Autoimmune Disease Drug Market Share by Application (2018-2029)
Figure 33. Europe Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 34. Germany Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. France Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. U.K. Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Italy Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Russia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. China Autoimmune Disease Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 41. China Autoimmune Disease Drug Market Share by Type (2018-2029)
Figure 42. China Autoimmune Disease Drug Market Share by Application (2018-2029)
Figure 43. Asia Autoimmune Disease Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 44. Asia Autoimmune Disease Drug Market Share by Type (2018-2029)
Figure 45. Asia Autoimmune Disease Drug Market Share by Application (2018-2029)
Figure 46. Asia Autoimmune Disease Drug Market Share by Region (2018-2029)
Figure 47. Japan Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. South Korea Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. China Taiwan Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. India Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Australia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Share by Type (2018-2029)
Figure 55. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Share by Application (2018-2029)
Figure 56. Middle East, Africa, and Latin America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 57. Brazil Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Mexico Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Turkey Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Israel Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. GCC Countries Autoimmune Disease Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 64. Pfizer Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 65. AbbVie Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 66. Eli Lilly Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 68. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 70. Roche Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 71. Biogen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 72. Amgen Revenue Growth Rate in Autoimmune Disease Drug Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries